Munir Mobassaleh, MD

Gastroenterologist, Division of Gastroenterology, Hepatology and Nutrition
Assistant Professor of Pediatrics (Part-time), Harvard Medical School
Education
Medical School
American University of Beirut
Beirut
Lebanon
Internship
American University of Beirut
Beirut
Lebanon
Residency
American University of Beirut
Beirut
Lebanon
Residency
Boston University, Boston City Hospital
Boston
MA
Fellowship
Tufts University, New England Medical Center
Boston
MA
Certifications
American Board of Pediatrics (Gastroenterology)
Professional History

At the onset of his career as a Pediatric Gastroenterologist, Dr. Mobassaleh’s focus was on basic research in the field of pathogenesis of Shigella Diarrhea and the developmental regulation of the Shiga toxin receptors.  He was funded through the National Institutes of Health to conduct this research. Dr. Mobassaleh truly enjoyed his time in the laboratory and appreciated the effects of laboratory research on the advancement of human health.  However, with time, he realized that his true interests were in the fields of direct patient care, teaching students, both residents and fellows, and the development of outreach programs.  Dr. Mobassaleh’s current focus is in those areas and he currently holds a particular role in the field of community outreach and community-physician relations.  His goals focus on collaboration with primary care physicians in order to bring subspecialty care plans into the community and allow patients easy and timely access to such care.

Approach to Care
I became interested in the biological sciences at early stage. During my college years, I realized that my true passion was in applying this knowledge into all aspects of patient care, both research and practice. This led me to enter the field of medicine.

My philosophy in practicing medicine is to treat all patients and their families with respect, and empower them to be actively involved in their own care and the process of decision making. My basic principle is to treat patients and families as I would treat my own. This shapes and influences my decisions in patient care.

Publications

Histological esophagitis: clinical and histological response to omeprazole in children. View Abstract
Developmental delay and growth failure caused by a peroxisomal disorder, dihydroxyacetonephosphate acyltransferase (DHAP-AT) deficiency. View Abstract
Proarrhythmia associated with cisapride in children. View Abstract
Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. View Abstract
Developmentally regulated Gb3 galactosyltransferase and alpha-galactosidase determine Shiga toxin receptors in intestine. View Abstract
Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. View Abstract
A quantitative immunostaining method for the measurement of UDP-galactose:lactosylceramide galactosyltransferase for the synthesis of globotriaosylceramide in rabbit small intestine and HeLa cells. View Abstract
Efficacy of cimetidine for gastric acid suppression in pediatric patients. View Abstract
Shiga toxin: intestinal cell receptors and pathophysiology of enterotoxic effects. View Abstract
Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosylceramide in microvillus membranes. View Abstract
Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine. View Abstract
Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin. View Abstract
Development of carbohydrate absorption in the fetus and neonate. View Abstract